These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
24. Evaluation of 0.4% ketorolac tromethamine ophthalmic solution versus 0.5% ketorolac tromethamine ophthalmic solution after phacoemulsification and intraocular lens implantation. Sandoval HP; De Castro LE; Vroman DT; Solomon KD J Ocul Pharmacol Ther; 2006 Aug; 22(4):251-7. PubMed ID: 16910866 [TBL] [Abstract][Full Text] [Related]
25. Reduction of interleukin 8 and platelet-derived growth factor levels by topical ketorolac, 0.45%, in patients with diabetic retinopathy. Schoenberger SD; Kim SJ; Shah R; Sheng J; Cherney E JAMA Ophthalmol; 2014 Jan; 132(1):32-7. PubMed ID: 24336915 [TBL] [Abstract][Full Text] [Related]
26. Ketorolac tromethamine 0.5% ophthalmic solution in the treatment of moderate to severe ocular inflammation after cataract surgery: a randomized, vehicle-controlled clinical trial. Heier J; Cheetham JK; Degryse R; Dirks MS; Caldwell DR; Silverstone DE; Rosenthal A Am J Ophthalmol; 1999 Mar; 127(3):253-9. PubMed ID: 10088733 [TBL] [Abstract][Full Text] [Related]
27. Reduction of vitreous prostaglandin E2 levels after topical administration of ketorolac 0.45%. Schoenberger SD; Kim SJ; Sheng J; Calcutt MW JAMA Ophthalmol; 2014 Feb; 132(2):150-4. PubMed ID: 24264034 [TBL] [Abstract][Full Text] [Related]
28. Effect of topical ketorolac 0.4%, nepafenac 0.1%, and bromfenac 0.09% on postoperative inflammation using laser flare photometry in patients having phacoemulsification. Sahu S; Ram J; Bansal R; Pandav SS; Gupta A J Cataract Refract Surg; 2015 Oct; 41(10):2043-8. PubMed ID: 26703278 [TBL] [Abstract][Full Text] [Related]
29. In vivo pharmacokinetics and in vitro pharmacodynamics of nepafenac, amfenac, ketorolac, and bromfenac. Walters T; Raizman M; Ernest P; Gayton J; Lehmann R J Cataract Refract Surg; 2007 Sep; 33(9):1539-45. PubMed ID: 17720067 [TBL] [Abstract][Full Text] [Related]
30. Aqueous penetration and biological activity of moxifloxacin 0.5% ophthalmic solution and gatifloxacin 0.3% solution in cataract surgery patients. Kim DH; Stark WJ; O'Brien TP; Dick JD Ophthalmology; 2005 Nov; 112(11):1992-6. PubMed ID: 16183125 [TBL] [Abstract][Full Text] [Related]
31. Effects of topical ketorolac tromethamine 0.45% on intraoperative miosis and prostaglandin E Jun JH; Yoo YS; Lim SA; Joo CK J Cataract Refract Surg; 2017 Apr; 43(4):492-497. PubMed ID: 28532934 [TBL] [Abstract][Full Text] [Related]
32. Topical 0.5% ketorolac vs 0.03% flurbiprofen for inhibition of miosis during cataract surgery. Solomon KD; Turkalj JW; Whiteside SB; Stewart JA; Apple DJ Arch Ophthalmol; 1997 Sep; 115(9):1119-22. PubMed ID: 9298051 [TBL] [Abstract][Full Text] [Related]
33. Incidence of postoperative posterior capsular opacification following treatment with diclofenac 0.1% and ketorolac 0.5% ophthalmic solutions: 3-year randomized, double-masked, prospective clinical investigation. Flach AJ; Dolan BJ Trans Am Ophthalmol Soc; 2000; 98():101-5; discussion 105-7. PubMed ID: 11190013 [TBL] [Abstract][Full Text] [Related]
34. Effect of Topical Nonsteroidal Anti-inflammatory Drugs on Pupillary Size During Uncomplicated Cataract Surgery. Rodríguez-García A; Hernández-Camarena JC; López-Jaime GR; Nava-García JA J Refract Surg; 2017 Apr; 33(4):236-242. PubMed ID: 28407163 [TBL] [Abstract][Full Text] [Related]
35. Fourth-generation fluoroquinolone penetration into the aqueous humor in humans. McCulley JP; Caudle D; Aronowicz JD; Shine WE Ophthalmology; 2006 Jun; 113(6):955-9. PubMed ID: 16603244 [TBL] [Abstract][Full Text] [Related]
36. Intraocular penetration of periocular ketorolac and efficacy in experimental uveitis. Rabiah PK; Fiscella RG; Tessler HH Invest Ophthalmol Vis Sci; 1996 Mar; 37(4):613-8. PubMed ID: 8595961 [TBL] [Abstract][Full Text] [Related]
38. Real-world opioid prescribing after cataract surgery among patients who received intracameral phenylephrine and ketorolac 1.0%/0.3. Jackson K; Wisely CE; Davis BM; Griffin B; Kim T Curr Med Res Opin; 2020 Dec; 36(12):2047-2052. PubMed ID: 33030383 [TBL] [Abstract][Full Text] [Related]
39. Prophylactic nepafenac and ketorolac versus placebo in preventing postoperative macular edema after uneventful phacoemulsification. Almeida DR; Khan Z; Xing L; Bakar SN; Rahim K; Urton T; El-Defrawy SR J Cataract Refract Surg; 2012 Sep; 38(9):1537-43. PubMed ID: 22795976 [TBL] [Abstract][Full Text] [Related]
40. Pharmacokinetics and efficacy of a ketorolac-loaded ocular coil in New Zealand white rabbits. Bertens CJF; Gijs M; Dias AAJ; van den Biggelaar FJHM; Ghosh A; Sethu S; Nuijts RMMA Drug Deliv; 2021 Dec; 28(1):400-407. PubMed ID: 33594935 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]